Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Modern Land (China) consent solicitation
The consent solicitation included multiple tranches of outstanding senior notes
HighTide Therapeutics HK$194.1 million IPO
We advised HighTide Therapeutics on its IPO and HKEX listing
Zhejiang Expressway $860 million rights issue
The H shares are listed on the Hong Kong Stock Exchange
Hollysys Automation $1.66 billion acquisition by Ascendent Capital Partners
We are advising Hollysys on the acquisition
Atour Lifestyle Holdings $174.4 million secondary offering
We advised Atour on a secondary offering of ADSs
Innovent Biologics HK$2.4 billion placement of shares
The shares are listed on the Hong Kong Stock Exchange
Weibo concurrent $330 million convertible notes and $63.5 million ADS offerings
The company also entered into an ADS lending agreement in connection with the ADS offering
Tencent $100 million strategic investment in Global Blue Group Holding
We advised Tencent on the transaction
WuXi XDC Cayman HK$3.68 billion IPO
The shares are listed on the HKEX
Genetron $126 million going-private transaction
We are separately advising Genetron and the special committee of its board on the transaction